The WACC of Alnylam Pharmaceuticals Inc (ALNY) is 8.6%.
| Range | Selected | |
| Cost of equity | 7.30% - 9.90% | 8.60% |
| Tax rate | 0.20% - 0.30% | 0.25% |
| Cost of debt | 9.10% - 9.10% | 9.10% |
| WACC | 7.4% - 9.9% | 8.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.75 | 0.89 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.30% | 9.90% |
| Tax rate | 0.20% | 0.30% |
| Debt/Equity ratio | 0.03 | 0.03 |
| Cost of debt | 9.10% | 9.10% |
| After-tax WACC | 7.4% | 9.9% |
| Selected WACC | 8.6% | |